LAG3 and neoplasm: The results showed that dual blockade of PD1 and LAG3 synergistically enhanced anti-tumor immunity by inhibiting tumor growth and enhanced infiltration of CD4+ and CD8+ T cells, combined with the increased production of IFN-γ and TNF-α (13).